The Government of India (GoI) has approved Roorkee-based Skymap Pharmaceuticals Private Ltd as the strategic buyer for the 100% disinvestment of Indian Medicines Pharmaceutical Corporation Ltd (IMPCL).
Established in July 1978, IMPCL is a profitable Central Public Sector Enterprise (CPSE) that manufactures and distributes standardised Ayurvedic and Unani medicines.